African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 7001-7009

  Lodolce, James P ^a   Kolodziej, Lauren E ^a   Rhee, Lesley ^a   Kariuki, Silvia N ^a   Franek, Beverly S ^a   McGreal, Nancy M ^a,c   Logsdon, Mark F ^a   Bartulis, Sarah J ^a   Perera, Minoli A ^a   Ellis, Nathan A ^a   Adams, Erin J ^a   Hanauer, Stephen B ^a   Jolly, Meenakshi ^b   Niewold, Timothy B ^a   Boone, David L ^a,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

^d Mailbox 9 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ENZYME; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

AFRICAN AMERICAN; ALLELE; ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; CELIAC DISEASE; COMPUTER MODEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ENTERITIS; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; HAPLOTYPE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; CHEMISTRY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; POLYMERASE CHAIN REACTION; PROTEIN QUATERNARY STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AUTOIMMUNITY; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, QUATERNARY; TRANSFECTION;

EID: 77953639241     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000324     Document Type: Article

References (46)

1. Coornaert, B., I. Carpentier, and R. Beyaert. 2009. A20: central gatekeeper in inflammation and immunity. J. Biol. Chem. 284: 8217-8221.
2. Wertz, I. E., K. M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D. L. Boone, et al. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699.
3. Boone, D. L., E. E. Turer, E. G. Lee, R. C. Ahmad, M. T. Wheeler, C. Tsui, P. Hurley, M. Chien, S. Chai, O. Hitotsumatsu, et al. 2004. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5: 1052-1060.
4. Lee, E. G., D. L. Boone, S. Chai, S. L. Libby, M. Chien, J. P. Lodolce, and A. Ma. 2000. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-2354.
5. Schmitz, R., M. L. Hansmann, V. Bohle, J. I. Martin-Subero, S. Hartmann, G. Mechtersheimer, W. Klapper, I. Vater, M. Giefing, S. Gesk, et al. 2009. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J. Exp. Med. 206: 981-989.
6. Kato, M., M. Sanada, I. Kato, Y. Sato, J. Takita, K. Takeuchi, A. Niwa, Y. Chen, K. Nakazaki, J. Nomoto, et al. 2009. Frequent inactivation of A20 in B-cell lymphomas. Nature 459: 712-716.
7. Compagno, M., W. K. Lim, A. Grunn, S. V. Nandula, M. Brahmachary, Q. Shen, F. Bertoni, M. Ponzoni, M. Scandurra, A. Califano, et al. 2009. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459: 717-721.
8. Pascual, V., L. Farkas, and J. Banchereau. 2006. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 18: 676-682.
9. Tsao, B. P., J. M. Grossman, G. Riemekasten, N. Strong, J. Kalsi, D. J. Wallace, C. J. Chen, C. S. Lau, E. M. Ginzler, R. Goldstein, et al. 2002. Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum. 46: 2678-2685. (Pubitemid 36118932)
10. Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939.
11. Lau, C. S., G. Yin, and M. Y. Mok. 2006. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15: 715-719.
12. Harley, J. B., M. E. Alarcón-Riquelme, L. A. Criswell, C. O. Jacob, R. P. Kimberly, K. L. Moser, B. P. Tsao, T. J. Vyse, C. D. Langefeld, S. K. Nath, et al; International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN). 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40: 204-210.
13. Hom, G., R. R. Graham, B. Modrek, K. E. Taylor, W. Ortmann, S. Garnier, A. T. Lee, S. A. Chung, R. C. Ferreira, P. V. Pant, et al. 2008. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358: 900-909.
14. Kozyrev, S. V., A. K. Abelson, J. Wojcik, A. Zaghlool, M. V. Linga Reddy, E. Sanchez, I. Gunnarsson, E. Svenungsson, G. Sturfelt, A. Jönsen, et al. 2008. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40: 211-216.
15. Graham, R. R., C. Cotsapas, L. Davies, R. Hackett, C. J. Lessard, J. M. Leon, N. P. Burtt, C. Guiducci, M. Parkin, C. Gates, et al. 2008. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40: 1059-1061.
16. Nath, S. K., S. Han, X. Kim-Howard, J. A. Kelly, P. Viswanathan, G. S. Gilkeson, W. Chen, C. Zhu, R. P. McEver, R. P. Kimberly, et al. 2008. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat. Genet. 40: 152-154.
17. Musone, S. L., K. E. Taylor, T. T. Lu, J. Nititham, R. C. Ferreira, W. Ortmann, N. Shifrin, M. A. Petri, M. I. Kamboh, S. Manzi, et al. 2008. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat. Genet. 40: 1062-1064.
18. Chapman, S. J., C. C. Khor, F. O. Vannberg, N. A. Maskell, C. W. Davies, E. L. Hedley, S. Segal, C. E. Moore, K. Knox, N. P. Day, et al. 2006. PTPN22 and invasive bacterial disease. Nat. Genet. 38: 499-500.
19. Plenge, R. M., C. Cotsapas, L. Davies, A. L. Price, P. I. de Bakker, J. Maller, I. Pe'er, N. P. Burtt, B. Blumenstiel, M. DeFelice, et al. 2007. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39: 1477-1482.
20. Thomson, W., A. Barton, X. Ke, S. Eyre, A. Hinks, J. Bowes, R. Donn, D. Symmons, S. Hider, I. N. Bruce, et al; Wellcome Trust Case Control Consortium; YEAR Consortium. 2007. Rheumatoid arthritis association at 6q23. Nat. Genet. 39: 1431-1433.
21. Fung, E. Y., D. J. Smyth, J. M. Howson, J. D. Cooper, N. M. Walker, H. Stevens, L. S. Wicker, and J. A. Todd. 2009. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 10: 188-191.
22. Trynka, G., A. Zhernakova, J. Romanos, L. Franke, K. A. Hunt, G. Turner, M. Bruinenberg, G. A. Heap, M. Platteel, A. W. Ryan, et al. 2009. Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 58: 1078-1083.
23. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
24. Barmada, M. M., S. R. Brant, D. L. Nicolae, J. P. Achkar, C. I. Panhuysen, T. M. Bayless, J. H. Cho, and R. H. Duerr. 2004. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm. Bowel Dis. 10: 513-520.
25. Nair, R. P., K. C. Duffin, C. Helms, J. Ding, P. E. Stuart, D. Goldgar, J. E. Gudjonsson, Y. Li, T. Tejasvi, B. J. Feng, et al; Collaborative Association Study of Psoriasis. 2009. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 41: 199-204.
26. Boonyasrisawat, W., D. Eberle, S. Bacci, Y. Y. Zhang, D. Nolan, E. V. Gervino, M. T. Johnstone, V. Trischitta, S. E. Shoelson, and A. Doria. 2007. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes. Diabetes 56: 499-505.
27. Bates, J. S., C. J. Lessard, J. M. Leon, T. Nguyen, L. J. Battiest, J. Rodgers, K. M. Kaufman, J. A. James, G. S. Gilkeson, J. A. Kelly, et al. 2009. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. 10: 470-477.
28. Frazer, K. A., D. G. Ballinger, D. R. Cox, D. A. Hinds, L. L. Stuve, R. A. Gibbs, J. W. Belmont, A. Boudreau, P. Hardenbol, S. M. Leal, et al; International HapMap Consortium. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
29. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
30. Xiao, R., and M. Boehnke. 2009. Quantifying and correcting for the winner's curse in genetic association studies. Genet. Epidemiol. 33: 453-462.
31. Gordon, D., M. A. Levenstien, S. J. Finch, and J. Ott. 2003. Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies. Pac. Symp. Biocomput. 490-501.
32. Gordon, D., S. J. Finch, M. Nothnagel, and J. Ott. 2002. Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum. Hered. 54: 22-33.
33. Gordon, D., S. C. Heath, X. Liu, and J. Ott. 2001. A transmission/ disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data. Am. J. Hum. Genet. 69: 371-380.
34. Niewold, T. B., J. A. Kelly, M. H. Flesch, L. R. Espinoza, J. B. Harley, and M. K. Crow. 2008. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum. 58: 2481-2487.
35. Wajant, H., and P. Scheurich. 2001. Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Int. J. Biochem. Cell Biol. 33: 19-32.
36. Shi, C. S., and J. H. Kehrl. 2003. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278: 15429-15434.
37. Song, H. Y., M. Rothe, and D. V. Goeddel. 1996. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc. Natl. Acad. Sci. USA 93: 6721-6725.
38. Komander, D., and D. Barford. 2008. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem. J. 409: 77-85.
39. Kudla, G., A. W. Murray, D. Tollervey, and J. B. Plotkin. 2009. Coding-sequence determinants of gene expression in Escherichia coli. Science 324: 255-258.
40. Chung, S. A., and L. A. Criswell. 2007. PTPN22: its role in SLE and autoimmunity. Autoimmunity 40: 582-590.
41. Barrett, J. C., S. Hansoul, D. L. Nicolae, J. H. Cho, R. H. Duerr, J. D. Rioux, S. R. Brant, M. S. Silverberg, K. D. Taylor, M. M. Barmada, et al; NIDDK IBD Genetics Consortium; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40: 955-962.
42. Baranathan, V., M. R. Stanford, R. W. Vaughan, E. Kondeatis, E. Graham, F. Fortune, W. Madanat, C. Kanawati, M. Ghabra, P. I. Murray, and G. R. Wallace. 2007. The association of the PTPN22 620W polymorphism with Behcet's disease. Ann. Rheum. Dis. 66: 1531-1533.
43. Alizadeh, B. Z., G. Valdigem, M. J. Coenen, A. Zhernakova, B. Franke, A. Monsuur, P. L. van Riel, P. Barrera, T. R. Radstake, B. O. Roep, et al. 2007. Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. Hum. Mol. Genet. 16: 2552-2559.
44. Takai, T. 2002. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2: 580-592.
45. Asano, K., T. Matsushita, J. Umeno, N. Hosono, A. Takahashi, T. Kawaguchi, T. Matsumoto, T. Matsui, Y. Kakuta, Y. Kinouchi, et al. 2009. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat. Genet. 41: 1325-1329.
46. Nitzan, O., M. Elias, and W. R. Saliba. 2006. Systemic lupus erythematosus and inflammatory bowel disease. Eur. J. Intern. Med. 17: 313-318.